Suppr超能文献

芬兰帕金森病患者的遗传风险因素。

Genetic risk factors in Finnish patients with Parkinson's disease.

机构信息

Institute of Clinical Medicine, Department of Neurology, University of Oulu, Oulu, Finland; Department of Neurology and Medical Research Center, Oulu University Hospital, Oulu, Finland.

Laboratory for Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.

出版信息

Parkinsonism Relat Disord. 2017 Dec;45:39-43. doi: 10.1016/j.parkreldis.2017.09.021. Epub 2017 Sep 29.

Abstract

INTRODUCTION

Variation contributing to the risk of Parkinson's disease (PD) has been identified in several genes and at several loci including GBA, SMPD1, LRRK2, POLG1, CHCHD10 and MAPT, but the frequencies of risk variants seem to vary according to ethnic background. Our aim was to analyze how variation in these genes contributes to PD in the Finnish population.

METHODS

The subjects consisted of 527 Finnish patients with early-onset PD, 325 patients with late-onset PD and 403 population controls. We screened for known genetic risk variants in GBA, SMPD1, LRRK2, POLG1, CHCHD10 and MAPT. In addition, DNA from 225 patients with early-onset Parkinson's disease was subjected to whole exome sequencing (WES).

RESULTS

We detected a significant difference in the length variation of the CAG repeat in POLG1 between patients with early-onset PD compared to controls. The p.N370S and p.L444P variants in GBA contributed to a relative risk of 3.8 in early-onset PD and 2.5 in late-onset PD. WES revealed five variants in LRRK2 and SMPD1 that were found in the patients but not in the Finnish ExAC sequences. These are possible risk variants that require further confirmation. The p.G2019S variant in LRRK2, common in North African Arabs and Ashkenazi Jews, was not detected in any of the 849 PD patients.

CONCLUSIONS

The POLG1 CAG repeat length variation and the GBA p.L444P variant are associated with PD in the Finnish population.

摘要

介绍

帕金森病(PD)风险的变异已在多个基因和多个基因座中被鉴定,包括 GBA、SMPD1、LRRK2、POLG1、CHCHD10 和 MAPT,但风险变异的频率似乎因种族背景而异。我们的目的是分析这些基因中的变异如何导致芬兰人群中的 PD。

方法

研究对象包括 527 名芬兰早发性 PD 患者、325 名晚发性 PD 患者和 403 名人群对照。我们筛查了 GBA、SMPD1、LRRK2、POLG1、CHCHD10 和 MAPT 中的已知遗传风险变异。此外,对 225 名早发性帕金森病患者的 DNA 进行了全外显子组测序(WES)。

结果

我们检测到 POLG1 中 CAG 重复序列长度变异在早发性 PD 患者与对照组之间存在显著差异。GBA 中的 p.N370S 和 p.L444P 变异导致早发性 PD 的相对风险为 3.8,晚发性 PD 的相对风险为 2.5。WES 揭示了 LRRK2 和 SMPD1 中的五个变体,这些变体仅在患者中发现,而不在芬兰 ExAC 序列中发现。这些可能是需要进一步确认的风险变体。在 849 名 PD 患者中未检测到常见于北非阿拉伯人和阿什肯纳兹犹太人的 LRRK2 p.G2019S 变体。

结论

POLG1 CAG 重复长度变异和 GBA p.L444P 变体与芬兰人群中的 PD 相关。

相似文献

1
Genetic risk factors in Finnish patients with Parkinson's disease.
Parkinsonism Relat Disord. 2017 Dec;45:39-43. doi: 10.1016/j.parkreldis.2017.09.021. Epub 2017 Sep 29.
2
Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?
Mol Genet Metab. 2019 Dec;128(4):470-475. doi: 10.1016/j.ymgme.2019.10.001. Epub 2019 Oct 13.
3
Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset.
Neurology. 2008 Jun 10;70(24):2277-83. doi: 10.1212/01.wnl.0000304039.11891.29. Epub 2008 Apr 23.
5
Carriers of both GBA and LRRK2 mutations, compared to carriers of either, in Parkinson's disease: Risk estimates and genotype-phenotype correlations.
Parkinsonism Relat Disord. 2019 May;62:179-184. doi: 10.1016/j.parkreldis.2018.12.014. Epub 2018 Dec 13.
7
Contribution of glucocerebrosidase mutation in a large cohort of sporadic Parkinson's disease in Taiwan.
Eur J Neurol. 2011 Oct;18(10):1227-32. doi: 10.1111/j.1468-1331.2011.03362.x. Epub 2011 Feb 22.
8
The contribution of Niemann-Pick SMPD1 mutations to Parkinson disease in Ashkenazi Jews.
Parkinsonism Relat Disord. 2015 Sep;21(9):1067-71. doi: 10.1016/j.parkreldis.2015.06.016. Epub 2015 Jun 19.
9
Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
Brain. 2015 Sep;138(Pt 9):2648-58. doi: 10.1093/brain/awv179. Epub 2015 Jun 27.
10
Homozygosity for the MTX1 c.184T>A (p.S63T) alteration modifies the age of onset in GBA-associated Parkinson's disease.
Neurogenetics. 2011 Nov;12(4):325-32. doi: 10.1007/s10048-011-0293-6. Epub 2011 Aug 12.

引用本文的文献

1
A Global Perspective of -Related Parkinson's Disease: A Narrative Review.
Genes (Basel). 2024 Dec 16;15(12):1605. doi: 10.3390/genes15121605.
2
Exome sequencing in Asian populations identifies low-frequency and rare coding variation influencing Parkinson's disease risk.
Nat Aging. 2025 Feb;5(2):205-218. doi: 10.1038/s43587-024-00760-7. Epub 2024 Nov 21.
3
GiOPARK Project: The Genetic Study of Parkinson's Disease in the Croatian Population.
Genes (Basel). 2024 Feb 19;15(2):255. doi: 10.3390/genes15020255.
4
Genetic Evidence for Endolysosomal Dysfunction in Parkinson's Disease: A Critical Overview.
Int J Mol Sci. 2023 Mar 28;24(7):6338. doi: 10.3390/ijms24076338.
5
Review of the epidemiology and variability of LRRK2 non-p.Gly2019Ser pathogenic mutations in Parkinson's disease.
Front Neurosci. 2022 Sep 20;16:971270. doi: 10.3389/fnins.2022.971270. eCollection 2022.
6
Emerging Therapeutic Strategies for Parkinson's Disease and Future Prospects: A 2021 Update.
Biomedicines. 2022 Feb 3;10(2):371. doi: 10.3390/biomedicines10020371.
7
ADHD and Neurodegenerative Disease Risk: A Critical Examination of the Evidence.
Front Aging Neurosci. 2022 Jan 25;13:826213. doi: 10.3389/fnagi.2021.826213. eCollection 2021.
8
A Practical Approach to Early-Onset Parkinsonism.
J Parkinsons Dis. 2022;12(1):1-26. doi: 10.3233/JPD-212815.
9
Gut-Brain Axis: Potential Factors Involved in the Pathogenesis of Parkinson's Disease.
Front Neurol. 2020 Aug 25;11:849. doi: 10.3389/fneur.2020.00849. eCollection 2020.
10
Whole Exome Sequencing Study of Parkinson Disease and Related Endophenotypes in the Italian Population.
Front Neurol. 2020 Jan 10;10:1362. doi: 10.3389/fneur.2019.01362. eCollection 2019.

本文引用的文献

1
Genetics of early-onset Parkinson's disease in Finland: exome sequencing and genome-wide association study.
Neurobiol Aging. 2017 May;53:195.e7-195.e10. doi: 10.1016/j.neurobiolaging.2017.01.019. Epub 2017 Feb 2.
2
Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden.
Neurobiol Aging. 2016 Sep;45:212.e5-212.e11. doi: 10.1016/j.neurobiolaging.2016.04.022. Epub 2016 May 3.
3
Parkinson-Related LRRK2 Mutation R1628P Enables Cdk5 Phosphorylation of LRRK2 and Upregulates Its Kinase Activity.
PLoS One. 2016 Mar 1;11(3):e0149739. doi: 10.1371/journal.pone.0149739. eCollection 2016.
4
Epidemiology of early-onset Parkinson's disease in Finland.
Parkinsonism Relat Disord. 2015 Aug;21(8):938-42. doi: 10.1016/j.parkreldis.2015.06.003. Epub 2015 Jun 4.
5
Late onset spinal motor neuronopathy is caused by mutation in CHCHD10.
Ann Neurol. 2015 Jan;77(1):163-72. doi: 10.1002/ana.24319. Epub 2014 Dec 12.
6
Confirmation of the association between LRRK2 R1628P variant and susceptibility to Parkinson's disease in the Thai population.
Parkinsonism Relat Disord. 2014 Sep;20(9):1018-21. doi: 10.1016/j.parkreldis.2014.06.013. Epub 2014 Jun 21.
7
A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement.
Brain. 2014 Aug;137(Pt 8):2329-45. doi: 10.1093/brain/awu138. Epub 2014 Jun 16.
8
Rare POLG1 CAG variants do not influence Parkinson's disease or polymerase gamma function.
Mitochondrion. 2014 Mar;15:65-8. doi: 10.1016/j.mito.2014.01.004. Epub 2014 Jan 31.
9
PredictSNP: robust and accurate consensus classifier for prediction of disease-related mutations.
PLoS Comput Biol. 2014 Jan;10(1):e1003440. doi: 10.1371/journal.pcbi.1003440. Epub 2014 Jan 16.
10
Variations of mitochondrial DNA polymerase γ in patients with Parkinson's disease.
J Neurol. 2013 Dec;260(12):3144-9. doi: 10.1007/s00415-013-7132-7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验